Anh Tuan DANG

Dr. Anh Tuan DANG

Department of Prosthodontics, Faculty of Dentistry, Haiphong University of Medicine and Pharmacy, Haiphong, Hải Phòng, Vietnam
+1
orcid
Ph.D. in Dentistry, Department of Prosthodontics, Faculty of...

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Materials
Verified
Journal Article
Open access
PDF file
Hai phamHai pham
Hai pham
MOMitsuaki Ono
Mitsuaki Ono
EHEmilio Hara
Emilio Hara
TNThi Thu Ha Nguyen
Thi Thu Ha Nguyen
Anh Tuan DANGAnh Tuan DANG
Anh Tuan DANG
TKTakuo Kuboki
Takuo Kuboki
Aging tissues present a progressive decline in homeostasis and regenerative capacities, which has been associated with degenerative changes in tissue-specific stem cells and stem cell niches. We hypothesized that amino acids could regulate the stem cell phenotype and differentiation ability of human bone marrow-derived mesenchymal stromal cells (hBMSCs). Thus, we performed a screening of 22 standard amino acids and found that D-tryptophan (10 μM) increased the number of cells positive for the early stem cell marker SSEA-4, and the gene expression levels of OCT-4, NANOG, and SOX-2 in hBMSCs. Comparison between D- and L-tryptophan isomers showed that the latter presents a stronger effect in inducing the mRNA levels of Oct-4 and Nanog, and in increasing the osteogenic differentiation of hBMSCs. On the other hand, L-tryptophan suppressed adipogenesis. The migration and colony-forming ability of hBMSCs were also enhanced by L-tryptophan treatment. In vivo experiments delivering L-tryptophan (50 mg/kg/day) by intraperitoneal injections for three weeks confirmed that L-tryptophan significantly increased the percentage of cells positive for SSEA-4, mRNA levels of Nanog and Oct-4, and the migration and colony-forming ability of mouse BMSCs. L-kynurenine, a major metabolite of L-tryptophan, also induced similar effects of L-tryptophan in enhancing stemness and osteogenic differentiation of BMSCs in vitro and in vivo, possibly indicating the involvement of the kynurenine pathway as the downstream signaling of L-tryptophan. Finally, since BMSCs migrate to the wound healing site to promote bone healing, surgical defects of 1 mm in diameter were created in mouse femur to evaluate bone formation after two weeks of L-tryptophan or L-kynurenine injection. Both L-tryptophan and L-kynurenine accelerated bone healing compared to the PBS-injected control group. In summary, L-tryptophan enhanced the stemness and osteoblastic differentiation of BMSCs and may be used as an essential factor to maintain the stem cell properties and accelerate bone healing and/or prevent bone loss.

Verified
Journal Article
Open access
PDF file
FKFang Ke
Fang Ke
YMYuki Murakami
Yuki Murakami
SKSeiji Kanda
Seiji Kanda
TSTakaki Shimono
Takaki Shimono
Anh Tuan DANGAnh Tuan DANG
Anh Tuan DANG
TNToshimasa Nishiyama
Toshimasa Nishiyama
Osteoporosis is a common bone disease, particularly in menopausal women. Herein, we screened four Kampo medicines (Unkeito (UKT), Kamishoyosan (KSS), Kamikihito (KKT), and Ninjinyoeito (NYT)), frequently used to treat menopausal syndromes, for their effects on receptor activator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast differentiation in RAW 264 cells. Considering that UKT exhibited the most potent effect, we examined its effect on RANKL-induced osteoclastogenesis, the induction of osteoclast apoptosis, and the mechanisms underlying its effects. UKT inhibits RANKL-induced osteoclast differentiation in the early stage and decreases osteoclast-related genes, including tartrate-resistant acid phosphatase (Trap), dendritic cell-specific transmembrane protein (Dcstamp), matrix metalloproteinase-9 (Mmp9), and cathepsin K (Ctsk). Specifically, UKT inhibits the nuclear factor of activated T cells 1 (NFATc1), which is essential for osteoclastogenesis. UKT increases Bcl6, which antagonizes NFATc1 and Dc-stamp, thereby blocking the progression of osteoclasts to maturation. UKT also decreased nuclear translocation by downregulating the activity of p65/NF-κB. In addition, UKT enhances mononuclear osteoclast apoptosis via activation of caspase-3. Herein, we demonstrate that UKT suppresses RANKL-mediated osteoclastogenesis via the Blimp1–Bcl6 and NF-κB signaling pathways and enhances mononuclear osteoclast apoptosis. Furthermore, UKT prevents bone loss in OVX mice. Thus, UKT might be a potential therapeutic agent for postmenopausal osteoporosis.

Verified
Journal Article
Open access
PDF file
YTYukie Tanaka
Yukie Tanaka
KAKyaw Thu Aung
Kyaw Thu Aung
MOMitsuaki Ono
Mitsuaki Ono
AMAkihiro Mikai
Akihiro Mikai
Anh Tuan DANGAnh Tuan DANG
Anh Tuan DANG
TOToshitaka Oohashi
Toshitaka Oohashi
Medication-related osteonecrosis of the jaw (MRONJ) is related to impaired bone healing conditions in the maxillomandibular bone region as a complication of bisphosphonate intake. Although there are several hypotheses for the onset of MRONJ symptoms, one of the possible causes is the inhibition of bone turnover and blood supply leading to bone necrosis. The optimal treatment strategy for MRONJ has not been established either. BMP-2, a member of the TGF-β superfamily, is well known for regulating bone remodeling and homeostasis prenatally and postnatally. Therefore, the objectives of this study were to evaluate whether cyclophosphamide/zoledronate (CY/ZA) induces necrosis of the bone surrounding the tooth extraction socket, and to examine the therapeutic potential of BMP-2 in combination with the hard osteoinductive biomaterial, β-tricalcium phosphate (β-TCP), in the prevention and treatment of alveolar bone loss around the tooth extraction socket in MRONJ-like mice models. First, CY/ZA was intraperitoneally administered for three weeks, and alveolar bone necrosis was evaluated before and after tooth extraction. Next, the effect of BMP-2/β-TCP was investigated in both MRONJ-like prevention and treatment models. In the prevention model, CY/ZA was continuously administered for four weeks after BMP-2/β-TCP transplantation. In the treatment model, CY/ZA administration was suspended after transplantation of BMP-2/β-TCP. The results showed that CY/ZA induced a significant decrease in the number of empty lacunae, a sign of bone necrosis, in the alveolar bone around the tooth extraction socket after tooth extraction. Histological analysis showed a significant decrease in the necrotic alveolar bone around tooth extraction sockets in the BMP-2/β-TCP transplantation group compared to the non-transplanted control group in both MRONJ-like prevention and treatment models. However, bone mineral density, determined by micro-CT analysis, was significantly higher in the BMP-2/β-TCP transplanted group than in the control group in the prevention model only. These results clarified that alveolar bone necrosis around tooth extraction sockets can be induced after surgical intervention under CY/ZA administration. In addition, transplantation of BMP-2/β-TCP reduced the necrotic alveolar bone around the tooth extraction socket. Therefore, a combination of BMP-2/β-TCP could be an alternative approach for both prevention and treatment of MRONJ-like symptoms.

Verified
Journal Article
Open access
PDF file
Anh Tuan DANGAnh Tuan DANG
Anh Tuan DANG
MOMitsuaki Ono
Mitsuaki Ono
ZWZiyi Wang
Ziyi Wang
ITIkue Tosa
Ikue Tosa
EHEmilio Hara
Emilio Hara
TOToshitaka Oohashi
Toshitaka Oohashi
The pathology of medication-related osteonecrosis of the jaw (MRONJ), often associated with antiresorptive therapy, is still not fully understood. Osteocyte networks are known to play a critical role in maintaining bone homeostasis and repair, but the exact condition of these networks in MRONJ is unknown. On the other hand, the local application of E-coli-derived Recombinant Human Bone Morphogenetic Protein 2/β-Tricalcium phosphate (E-rhBMP-2/β-TCP) has been shown to promote bone regeneration and mitigate osteonecrosis in MRONJ-like mouse models, indicating its potential therapeutic application for the treatment of MRONJ. However, the detailed effect of BMP-2 treatment on restoring bone integrity, including its osteocyte network, in an MRONJ condition remains unclear. Therefore, in the present study, by applying a scanning electron microscope (SEM) analysis and a 3D osteocyte network reconstruction workflow on the alveolar bone surrounding the tooth extraction socket of an MRONJ-like mouse model, we examined the effectiveness of BMP-2/β-TCP therapy on the alleviation of MRONJ-related bone necrosis with a particular focus on the osteocyte network and alveolar bone microstructure (microcrack accumulation). The 3D osteocyte dendritic analysis showed a significant decrease in osteocyte dendritic parameters along with a delay in bone remodeling in the MRONJ group compared to the healthy counterpart. The SEM analysis also revealed a notable increase in the number of microcracks in the alveolar bone surface in the MRONJ group compared to the healthy group. In contrast, all of those parameters were restored in the E-rhBMP-2/β-TCP-treated group to levels that were almost similar to those in the healthy group. In summary, our study reveals that MRONJ induces osteocyte network degradation and microcrack accumulation, while application of E-rhBMP-2/β-TCP can restore a compromised osteocyte network and abrogate microcrack accumulation in MRONJ.

12 December 2025 in Frontiers in Dental Medicine
Verified
Journal Article
Open access
PDF file
JHJuan Hernández-Cabanillas
Juan Hernández-Cabanillas
LHLouis Hardan
Louis Hardan
Carlos Cuevas-SuárezCarlos Cuevas-Suárez
Carlos Cuevas-Suárez
IOIván Olivares-Acosta
Iván Olivares-Acosta
Anh Tuan DANGAnh Tuan DANG
Anh Tuan DANG
RBRim Bourgi
Rim Bourgi
Background: Understanding the performance of calcium silicate-based pulp capping materials is essential for clinicians seeking to preserve pulp vitality in cases of carious exposure, dental trauma, or developmental defects. Objective: This study aimed to compare the physicochemical and biological properties of four pulp capping materials: Mineral Trioxide Aggregate (MTA), Biodentine®, TheraCal LC, and TheraCal PT. Methods: Compressive strength, shear bond strength to composite resin, radiopacity, in vitro biomineralization, and cytocompatibility with human dental pulp stem cells (hDPSCs) were evaluated under standardized conditions. Statistical analysis was performed using one-way analysis of variance (ANOVA) and Tukey's post hoc test ( α = 0.05). Results: TheraCal PT exhibited the highest compressive and bond strength ( p < 0.001), while MTA showed the greatest radiopacity ( p < 0.001). Biodentine and MTA demonstrated superior biomineralization with abundant calcium phosphate crystal formation. In cell viability assays, Biodentine and TheraCal PT performed similarly to the control ( p > 0.024), whereas Biodentine and TheraCal LC showed significantly reduced viability ( p < 0.001). Conclusions: Resin-modified materials offer advantages in mechanical performance and bonding but may compromise biomineralization and biocompatibility. Water-based materials like MTA remain superior in bioactivity and cellular response. Clinicians should balance physical properties with biological outcomes when selecting pulp capping agents.

14 July 2025 in Blood Advances
Verified
Journal Article
Open access
ITIkue Tosa
Ikue Tosa
MOMitsuaki Ono
Mitsuaki Ono
Anh Tuan DANGAnh Tuan DANG
Anh Tuan DANG
ZWZiyi Wang
Ziyi Wang
MKMaiko Kimura
Maiko Kimura
TKTakuo Kuboki
Takuo Kuboki
Ectopic bone marrow (eBM) holds tremendous potential as an artificial organ, serving not only in stem cell transplantation therapies but also as a controlled experimental system for analyzing cellular dynamics and interactions between cells and the matrix during the formation, maintenance, and aging of BM. Although bone morphogenetic protein-2 (BMP-2) has been reported to induce eBM formation, it remains unproven whether BMP-2–induced eBM (BMP-eBM) can provide a functional BM niche that is comparable with native BM in long bones (LB-BM). In this study, through the use of single-cell RNA sequencing and transplantation models, we demonstrate that BMP-eBM displays a microstructure, cellular composition, and functional hematopoiesis similar to LB-BM. BMP-eBM establishes an optimized microenvironment capable of supporting hematopoietic stem cells and CXC chemokine ligand 12 (CXCL12)–abundant reticular (CAR) cells, which are critical components of the BM niche. BMP-eBM was able to significantly restore survival in irradiated mice. Through parabiosis and cell transplantation experiments, we identified that in situ adipose tissue–derived CD51highCxcl12-GFP– cells are the principal source of CAR cells within BMP-eBM. Furthermore, BMP-eBM can be isolated and after preconditioning, retransplanted as an independent, functional hematopoietic organ. In conclusion, our study confirms that BMP-eBM functions effectively as a hematopoietic organ, capable of supporting and maintaining a functional BM niche. These findings underscore BMP-2 as a crucial molecule for eBM generation and suggest its potential for addressing BM-related diseases and for use as a platform for in vitro and ex vivo biomedical applications.